Hasbani Follows Up The Death Of Farah Kassab And Issues Two Decisions And Two Letters To The General

Hasbani Follows up the Death of Farah Kassab and Issues Two Decisions and Two Letters to the General Prosecution and the Order of Physicians

The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

In the context of following up the death of Farah Kassab after she underwent a cosmetic surgery in a specialized hospital in cosmetic surgeries,

Health Minister Ghassan Hasbani took the following actions:

The issuance of a decision on the prevention of surgical operations that require a general anesthetic in day hospitals or other cosmetic surgery clinics.
The issuance of a decision on the prevention of surgical operations that require a general anesthetic in Dr. Nader Saab hospital specialized in cosmetic surgery.
The issuance of a letter to the Public Prosecutor to investigate into the death of Farah Kassab.
The issuance of a letter to the Lebanese Order of Physicians in Beirut to conduct necessary investigations into the death of Farah Kassab, and give the Order a period of two weeks to clarify some technical medical points and answer questions asked by Health Minister concerning the death of the said woman.

These steps came to complete the immediate oral decision of Health Minister Ghassan Hasbani to cease operations in the said clinic after the woman's death, and the written decision issued Friday 2 June 2017 which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not performed in places other than specialized hospitals which include an intensive care division that holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A03FA03	MOTILIUM	B	Domperidone - 10mg	10mg	Tablet	353,431 L.L
A03FA03	MODODOM	G	Domperidone - 10mg	10mg	Tablet, film coated	147,823 L.L
A03FA03	MOTILAT	G	Domperidone - 10mg	10mg	Tablet	221,734 L.L
A03FA03	MOTILIUM ORAL	B	Domperidone - 5mg/5ml	5mg/5ml	Suspension	377,620 L.L
A03FA03	MOTIDOL ODT	G	Domperidone - 10mg	10mg	Tablet, orodispersible	259,810 L.L
A03FA01	METOCLOPRAMIDE	G	Metoclopramide HCl - 10mg	10mg	Tablet	172,012 L.L
A03FA01	METOCLOPRAMIDE S.A.L.F.	G	Metoclopramide HCl - 10mg/2ml	10mg/2ml	Injectable solution	255,330 L.L
A03FA01	METORAM	G	Metoclopramide HCl - 10mg/2ml	10mg/2ml	Injectable solution	421,071 L.L
A03FA01	METORAM	G	Metoclopramide HCl - 10mg/2ml	10mg/2ml	Injectable solution	3,026,845 L.L
A03E	MEPHIGASTRYL	G	Belladone powder - 0.005g, Magnesium hydroxide - 0.1g, Meprobamate - 0.1g, Prochlorperazine maleate - 0.01g		Capsule	296,925 L.L
A03AX58	METEOSPASMYL	B	Alverine citrate - 60mg, Simethicone - 300mg		Capsule	481,096 L.L
A03AX13	MOSAR PLUS	B	Mosapride citrate - 5mg, Simethicone - 200mg		Tablet, coated	865,435 L.L
A02BC05	METAPRO	G	Esomeprazole - 40mg	40mg	Tablet, gastroresistant	639,669 L.L
A02BC01	MEDIZOLE GP	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	503,941 L.L
A02BB01	MISOFAR	G	Misoprostol - 200mcg	200mcg	Tablet	1,546,763 L.L
A02BB01	MISOFAR	G	Misoprostol - 25mcg	25mcg	Tablet	1,855,846 L.L
A02AF02	MAALOX PLUS	B	Dimethicone - 25mg, Aluminium hydroxide - 200mg, Magnesium hydroxide - 200mg		Tablet, chewable	166,636 L.L
A02AF02	MAALOX PLUS	B	Simethicone - 25mg/5ml, Aluminium hydroxide - 175mg/5ml, Magnesium hydroxide - 200mg/5ml		Suspension	438,093 L.L
A01AB09	MICONAZ	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	229,093 L.L
A01AB09	MICOZOLE	G	Miconazole - 20mg/g	20mg/g	Gel	104,820 L.L
A01AB09	MYCOHEAL	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	210,983 L.L

...